 |
|
|
| |
Rapid Initiation of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Patients With Human
Immunodeficiency Virus (HIV)-1 Infection: Age, Race/Ethnicity, and Gender Subgroup Analyses From the DIAMOND Study
|
| |
| |
17th EACS 2019 Nov 6-9 Basel
Reported by Jules Levin
David Anderson,1,* Robert Bolan,2 Edwin DeJesus,3 Jose Guillermo Castro,4 Richard Bruce Simonson,1 Patricia Cosler,1 Sareh Seyedkazemi,1 Donghan Luo,5 Keith Dunn1
1Janssen Scientific Affairs, LLC, Titusville, NJ, USA; 2Los Angeles LGBT Center, Los Angeles, CA, USA; 3Orlando Immunology Center, Orlando, FL, USA; 4University of Miami, Miami, FL, USA; 5Janssen Research & Development, LLC, Titusville, NJ, USA
|
| |
|
|
|
|
|
